Explore medication options for kidney disease and potential side effects. Learn the best treatment options to slow ...

Several hundred units of counterfeit Ozempic (semaglutide) injection 1 mg have been found in the United States. The FDA ...

A patient with end-stage kidney disease successfully received a genetically engineered porcine kidney and was released from ...

April 14 (UPI) --The U.S. Food and Drug Administration on Monday warned consumers and pharmacies that fake versions of Ozempic ... A patient with end-stage kidney disease successfully received ...

The FDA approved semaglutide for weight ... Agency’s backing came after a 2024 trial showed Ozempic cutting the risk of kidney disease-related events in diabetic patients by 24%.

March is National Kidney Month – a time to raise awareness and learn more about kidney health and kidney disease. Earlier in 2025, the U.S. Food and Drug Administration (FDA) approved Ozempic ...

Some celebrities who have spoken out about using the weight loss drug include Oprah Winfrey, Kelly Clarkson, and James Corden ...

Wegovy was approved in the indication last year. Two months ago, the FDA signed off on Ozempic to reduce the risk of worsening kidney disease and cardiovascular death in those with type 2 diabetes ...

“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...

Recent FDA actions include ... In addition, semaglutide (Ozempic, Novo Nordisk) received an expanded indication to reduce risk for worsening kidney disease, kidney failure and CV death for ...

Compounded semaglutide and Ozempic are different products ... problems in people who also have cardiovascular disease reduce the risk of worsening kidney disease and death from cardiovascular ...

Novo Nordisk's Phase 3b STRIDE trial shows Ozempic improves walking distance in peripheral artery disease, while the SOUL trial finds Rybelsus lowers cardiovascular risk by 14%.